Marketing-authorisation holder · United States
Monarch Pharms
21 medicines in 1 country, as authorisation holder.
Group structure
Part of
MonarchPharmaceutical groupOther companies in the group
Headquarters not stated1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
21 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CORTISPORIN0.5%; 3.5MG BASE/GM; 10,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Cream | Hydrocortisone, Neomycin, Polymyxin b | United States | Not marketed | 1963 |
| CORTISPORIN400 UNITS/GM; 1%; 3.5MG BASE/GM; 5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Ointment | Bacitracin, Hydrocortisone, Neomycin, Polymyxin b | United States | Not marketed | 1957 |
| CORTISPORIN1%; 3.5MG BASE/ML; 10,000 UNITS/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution/drops | Hydrocortisone, Neomycin, Polymyxin b | United States | Not marketed | 1975 |
| CORTISPORIN1%; 3.5mg base/ml; 10,000 units/ml · Suspension/drops | Hydrocortisone, Neomycin, Polymyxin b | United States | Not marketed | 1964 |
| DERMACORT1% · Cream | Hydrocortisone | United States | Not marketed | 1973 |
| KEMADRIN2mg | 5mg · Tablet | Procyclidine | United States | Not marketed | 1955 |
| MENEST0.3mg | 0.625mg | 1.25mg | 2.5mg · Tablet | Conjugated estrogens, Esterified | United States | Not marketed | 1977 |
| NEOSPORIN0.025mg/ml; 1.75mg base/ml; 10,000 units/ml · Solution/drops | Gramicidin, Neomycin, Polymyxin b | United States | Not marketed | 1968 |
| NEOSPORIN G.U. IRRIGANT40mg base/ml; 200,000 units/ml | 800mg base/20ml; 4,000,000 units/20ml (eq 40mg base/ml · Solution | Neomycin, Polymyxin b | United States | Marketed | 1966 |
| PEDIOTIC1%; 3.5mg base/ml; 10,000 units/ml · Suspension/drops | Hydrocortisone, Neomycin, Polymyxin b | United States | Not marketed | 1987 |
| POLYSPORIN500 UNITS/GM; 10,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for s or e reasons** · Ointment | Bacitracin, Polymyxin b | United States | Not marketed | 1974 |
| PROCTOCORT1% · Cream | Hydrocortisone | United States | Not marketed | 1973 |
| PROLOPRIM100mg | 200mg · Tablet | Trimethoprim | United States | Not marketed | 1980 |
| QUIBRON-T300mg · Tablet | Theophylline | United States | Not marketed | 1985 |
| QUIBRON-T/SR300mg · Tablet, extended release | Theophylline | United States | Not marketed | 1983 |
| SEPTRA400mg; 80mg · Tablet | Sulfamethoxazole, Trimethoprim | United States | Not marketed | 1973 |
| SEPTRA200MG/5ML; 40MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Suspension | Sulfamethoxazole, Trimethoprim | United States | Not marketed | 1975 |
| SEPTRA80MG/ML; 16MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Sulfamethoxazole, Trimethoprim | United States | Not marketed | 1981 |
| SEPTRA DS800mg; 160mg · Tablet | Sulfamethoxazole, Trimethoprim | United States | Not marketed | 1973 |
| SEPTRA GRAPE200MG/5ML; 40MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Suspension | Sulfamethoxazole, Trimethoprim | United States | Not marketed | 1975 |
| VIROPTIC1% · Solution/drops | Trifluridine | United States | Marketed | 1980 |